Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

Workflow for Criticality Assessment Applied in Biopharmaceutical Process Validation Stage 1.

Zahel T, Marschall L, Abad S, Vasilieva E, Maurer D, Mueller EM, Murphy P, Natschläger T, Brocard C, Reinisch D, Sagmeister P, Herwig C.

Bioengineering (Basel). 2017 Oct 12;4(4). pii: E85. doi: 10.3390/bioengineering4040085.

2.

Addition of thrombin reduces the recovery of extracellular vesicles from blood plasma.

Arakelyan A, Fitzgerald W, Vagida M, Vasilieva E, Margolis L, Grivel JC.

J Circ Biomark. 2016 Oct 4;5:1849454416663648. doi: 10.1177/1849454416663648. eCollection 2016 Jan-Dec.

3.

[Immunological Analysis of Human Atherosclerotic Plaques in ex vivo Culture System].

Vorobyova DA, Lebedev AM, Vagida MS, Ivanova OI, Felker EI, Gontarenko VN, Shpektor AV, Margolis LB, Vasilieva EY.

Kardiologiia. 2016 Dec;56(11):78-85. Russian.

PMID:
28290822
4.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

PMID:
28081827
5.

Flow analysis of individual blood extracellular vesicles in acute coronary syndrome.

Vagida M, Arakelyan A, Lebedeva A, Grivel JC, Shpektor A, Vasilieva E, Margolis L.

Platelets. 2017 Mar;28(2):165-173. doi: 10.1080/09537104.2016.1212002. Epub 2016 Sep 5.

PMID:
27595614
6.

Cytomegalovirus-Productive Infection Is Associated With Acute Coronary Syndrome.

Nikitskaya E, Lebedeva A, Ivanova O, Maryukhnich E, Shpektor A, Grivel JC, Margolis L, Vasilieva E.

J Am Heart Assoc. 2016 Aug 20;5(8). pii: e003759. doi: 10.1161/JAHA.116.003759.

7.

Cytomegalovirus in Plasma of Acute Coronary Syndrome Patients.

Nikitskaya EA, Grivel JC, Maryukhnich EV, Lebedeva AM, Ivanova OI, Savvinova PP, Shpektor AV, Margolis LB, Vasilieva EY.

Acta Naturae. 2016 Apr-Jun;8(2):102-7.

8.

Analysis of Extracellular Vesicles Using Magnetic Nanoparticles in Blood of Patients with Acute Coronary Syndrome.

Vagida MS, Arakelyan A, Lebedeva AM, Grivel JC, Shpektor AV, Vasilieva EY, Margolis LB.

Biochemistry (Mosc). 2016 Apr;81(4):382-391. doi: 10.1134/S0006297916040088.

9.

Interactions of two large antiviral polyamides with the long control region of HPV16.

Vasilieva E, Niederschulte J, Song Y, Harris GD Jr, Koeller KJ, Liao P, Bashkin JK, Dupureur CM.

Biochimie. 2016 Aug;127:103-14. doi: 10.1016/j.biochi.2016.04.022. Epub 2016 May 4.

10.

Structural, biocomplexation and gene delivery properties of hydroxyethylated gemini surfactants with varied spacer length.

Zakharova LY, Gabdrakhmanov DR, Ibragimova AR, Vasilieva EA, Nizameev IR, Kadirov MK, Ermakova EA, Gogoleva NE, Faizullin DA, Pokrovsky AG, Korobeynikov VA, Cheresiz SV, Zuev YF.

Colloids Surf B Biointerfaces. 2016 Apr 1;140:269-277. doi: 10.1016/j.colsurfb.2015.12.045. Epub 2015 Dec 29.

PMID:
26764110
11.

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees.

Circ Heart Fail. 2016 Jan;9(1). pii: e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.

12.

[Effect of Remote Ischemic Preconditioning and Postconditioning on Blood Flow in the Infarct-Related Artery and Endothelial Function in Patients With ST-Elevation Myocardial Infarction].

Manchurov VN, Ryazankina NB, Reztsov RY, Skrypnik DV, Vasilieva EY, Shpektor AV.

Kardiologiia. 2016 Jan;56(1):6-11. Russian.

PMID:
28294724
13.

Synthesis and comparison of the biological activity of monocyclic phosphonate, difluorophosphonate and phosphate analogs of the natural AChE inhibitor cyclophostin.

Martin BP, Vasilieva E, Dupureur CM, Spilling CD.

Bioorg Med Chem. 2015 Dec 15;23(24):7529-34. doi: 10.1016/j.bmc.2015.10.044. Epub 2015 Oct 30.

PMID:
26585276
14.

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.

Weisz G, Généreux P, Iñiguez A, Zurakowski A, Shechter M, Alexander KP, Dressler O, Osmukhina A, James S, Ohman EM, Ben-Yehuda O, Farzaneh-Far R, Stone GW; RIVER-PCI investigators.

Lancet. 2016 Jan 9;387(10014):136-45. doi: 10.1016/S0140-6736(15)00459-6. Epub 2015 Oct 22.

PMID:
26474810
15.

Siege of Leningrad Survivors Phenotyping and Biospecimen Collection.

Rotar OP, Moguchaya EV, Boyarinova MA, Alieva AS, Orlov AV, Vasilieva EY, Yudina VA, Anisimov SV, Konradi AO.

Biopreserv Biobank. 2015 Oct;13(5):371-5. doi: 10.1089/bio.2015.0018. Epub 2015 Sep 29.

PMID:
26417917
16.

[THE TEST OF GENERATION OF THROMBIN IN DYNAMICS IN PATIENTS AFTER TRANSCUTANEOUS CORONARY INTERVENTION].

Napalkova OS, Emanuel VL, Karpenko MA, Berezovskaia GA, Iakovlev AN, Yudina VA, Vasilieva EY, Lapin SV, Tishkov AV, Hisheva NA.

Klin Lab Diagn. 2015 Apr;60(4):40-5. Russian.

PMID:
26189289
17.

134 Large antiviral polyamide-DNA interactions.

Vasilieva E, Song Y, Koeller KJ, Davis Harris G, Bashkin JK, Dupureur CM.

J Biomol Struct Dyn. 2015;33 Suppl 1:86-7. doi: 10.1080/07391102.2015.1032767. No abstract available.

PMID:
26103344
18.

Molecular barriers to processes of genetic reprogramming and cell transformation.

Chestkov IV, Khomyakova EA, Vasilieva EA, Lagarkova MA, Kiselev SL.

Biochemistry (Mosc). 2014 Dec;79(12):1297-307. doi: 10.1134/S0006297914120037. Review.

19.

Rat hormone sensitive lipase inhibition by cyclipostins and their analogs.

Vasilieva E, Dutta S, Malla RK, Martin BP, Spilling CD, Dupureur CM.

Bioorg Med Chem. 2015 Mar 1;23(5):944-52. doi: 10.1016/j.bmc.2015.01.028. Epub 2015 Jan 22.

20.

[TUMOR SUPPRESSOR p63 REGULATES EXPRESSION OF UBIQUITIN LIGASE Pirh2].

Daks AA, Petukhov AV, Shuvalov OY, Vasilieva EA, Melino G, Barlev NA, Fedorova OA.

Tsitologiia. 2015;57(12):876-9. Russian.

PMID:
26995965

Supplemental Content

Loading ...
Support Center